These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 414908)

  • 1. Effect of triiodothyronine on thyroliberin-induced somatotropin release in patients with acromegaly.
    Pawlikowski M; Owczarczyk I
    Endokrynol Pol; 1977; 28(6):497-501. PubMed ID: 414908
    [No Abstract]   [Full Text] [Related]  

  • 2. Plasma growth hormone response to thyrotropin-releasing hormone in patients with active acromegaly.
    Faglia G; Beck-Peccoz P; Ferrari C; Travaglini P; Ambrosi B; Spada A
    J Clin Endocrinol Metab; 1973 Jun; 36(6):1259-62. PubMed ID: 4196265
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of thyroliberin (TRH), bromocriptine and cyproheptadine on somatotropin secretion in acromegaly.
    Pawlikowski M; Strejczek H; Owczarczyk I; Komorowski J
    Mater Med Pol; 1980; 12(1-2):70-3. PubMed ID: 6799708
    [No Abstract]   [Full Text] [Related]  

  • 4. [Growth hormone secretion in relation to changes in thyrotropic hormone after thyroliberin in patients with acromegaly and dopaminergic stimulation (author's transl)].
    Felt V; Nedvídková J
    Cas Lek Cesk; 1982 Apr; 121(16):489-93. PubMed ID: 6807547
    [No Abstract]   [Full Text] [Related]  

  • 5. Increase of serum growth hormone concentration following thyrotropin-releasing hormone injection in patients with acromegaly or gigantism.
    Irie M; Tsushima T
    J Clin Endocrinol Metab; 1972 Jul; 35(1):97-100. PubMed ID: 4624350
    [No Abstract]   [Full Text] [Related]  

  • 6. Serum growth hormone and prolactin response to thyrotropin-releasing hormone in patients with acromegaly before and after surgery.
    Samaan NA; Leavens ME; Jesse RH
    J Clin Endocrinol Metab; 1974 Jun; 38(6):957-63. PubMed ID: 4208807
    [No Abstract]   [Full Text] [Related]  

  • 7. Decrease of plasma somatotropin levels following thyroliberin (TRH) administration in patients with hyperthyroidism.
    Pawlikowski M; Owczarczyk I
    Endokrinologie; 1979; 73(3):363-6. PubMed ID: 115673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth hormone and changes in the secretion of thyrotropic hormone after thyrotropin-releasing hormone (TRH): ineffectiveness of dopaminergic stimulation.
    Felt V; Nedvídková J
    Endokrinologie; 1982 Oct; 80(2):201-6. PubMed ID: 6819130
    [No Abstract]   [Full Text] [Related]  

  • 9. [The use of thyreoliberin VUFB in the diagnosis of acromegaly (author's transl)].
    Felt V; Nedvídková J; Shameti H; Kasafírek E
    Cas Lek Cesk; 1979 Feb; 118(8):232-4. PubMed ID: 109212
    [No Abstract]   [Full Text] [Related]  

  • 10. Failure of somatostatin to suppress thyrotropin releasing factor and luteinizing hormone releasing factor-induced growth hormone release in acromegaly.
    Giustina G; Reschini E; Peracchi M; Cantalamessa L; Cavagnini F; Pinto M; Bulgheroni P
    J Clin Endocrinol Metab; 1974 May; 38(5):906-9. PubMed ID: 4207370
    [No Abstract]   [Full Text] [Related]  

  • 11. Oral thyrotropin-releasing hormone (TRH) test in acromegaly.
    Marek J; Límanová Z; Srámková J
    Endokrinologie; 1981 Oct; 78(1):57-66. PubMed ID: 6797816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Peripheral thyroid function and TRH-TSH test in patients with acromegaly].
    Heberling HJ; Heilmann W; Ulrich FE; Schneyer U
    Z Gesamte Inn Med; 1981 Apr; 36(8):306-8. PubMed ID: 6792802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The spectrum of pituitary growth hormone responses to pharmacological stimuli in acromegaly.
    Hanew K; Kokubun M; Sasaki A; Mouri T; Yoshinaga K
    J Clin Endocrinol Metab; 1980 Aug; 51(2):292-7. PubMed ID: 6772662
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of thyrotropin-releasing hormone on growth hormone release in normal subjects and in patients with depression, anorexia nervosa and acromegaly.
    Maeda K
    Kobe J Med Sci; 1976 Dec; 22(4):263-72. PubMed ID: 829578
    [No Abstract]   [Full Text] [Related]  

  • 15. Inappropriate secretion of thyrotropin: discordance between the suppressive effects of corticosteroids and thyroid hormone.
    Smallridge RC; Wartofsky L; Dimond RC
    J Clin Endocrinol Metab; 1979 Apr; 48(4):700-5. PubMed ID: 107182
    [No Abstract]   [Full Text] [Related]  

  • 16. Somatostatin sensitivity and growth hormone responses to releasing hormones and bromocryptine in acromegaly.
    Pieters GF; Romeijn JE; Smals AG; Kloppenborg PW
    J Clin Endocrinol Metab; 1982 May; 54(5):942-8. PubMed ID: 6120951
    [No Abstract]   [Full Text] [Related]  

  • 17. Elevations in plasma growth hormone concentration after luteinizing hormone-releasing hormone (LRH) in patients with active acromegaly.
    Faglia G; Beck-Peccoz P; Travaglini P; Paracchi A; Spada A; Lewin A
    J Clin Endocrinol Metab; 1973 Aug; 37(2):338-40. PubMed ID: 4198260
    [No Abstract]   [Full Text] [Related]  

  • 18. Childhood acromegaly: successful therapy with conventional radiation and effects of chlorpromazine on growth hormone and prolactin secretion.
    AvRuskin TW; Sau K; Tang S; Juan C
    J Clin Endocrinol Metab; 1973 Sep; 37(3):380-8. PubMed ID: 4206490
    [No Abstract]   [Full Text] [Related]  

  • 19. [Abnormal reaction of GH to TRH and l-dopa stimulation in acromegaly].
    Haniu K; Taya T; Aida M; Yoshinaga K
    Horumon To Rinsho; 1976 Nov; 24(11):1145-50. PubMed ID: 827402
    [No Abstract]   [Full Text] [Related]  

  • 20. [Studies of hypothalamic control of somatotropin incretion in acromegaly].
    Liuzzi A; Chiodini PG; Botalla L; Cremascoli G; Tosi M
    Folia Endocrinol; 1973 Dec; 26(6):503-9. PubMed ID: 4801261
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.